BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 30430043)

  • 1. Interaction between
    Zhao J; Yu W
    PeerJ; 2018; 6():e5931. PubMed ID: 30430043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coinfection with
    Keown K; Reid A; Moore JE; Taggart CC; Downey DG
    Eur Respir Rev; 2020 Dec; 29(158):. PubMed ID: 33208485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary Metabolites Produced during Aspergillus fumigatus and Pseudomonas aeruginosa Biofilm Formation.
    Bastos RW; Akiyama D; Dos Reis TF; Colabardini AC; Luperini RS; de Castro PA; Baldini RL; Fill T; Goldman GH
    mBio; 2022 Aug; 13(4):e0185022. PubMed ID: 35856657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Under nonlimiting iron conditions pyocyanin is a major antifungal molecule, and differences between prototypic Pseudomonas aeruginosa strains.
    Sass G; Nazik H; Chatterjee P; Stevens DA
    Med Mycol; 2021 May; 59(5):453-464. PubMed ID: 32827431
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Reece E; Doyle S; Greally P; Renwick J; McClean S
    Front Microbiol; 2018; 9():1205. PubMed ID: 29922270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of Pseudomonas aeruginosa Mutants Indicate Pyoverdine as the Central Factor in Inhibition of Aspergillus fumigatus Biofilm.
    Sass G; Nazik H; Penner J; Shah H; Ansari SR; Clemons KV; Groleau MC; Dietl AM; Visca P; Haas H; Déziel E; Stevens DA
    J Bacteriol; 2018 Jan; 200(1):. PubMed ID: 29038255
    [No Abstract]   [Full Text] [Related]  

  • 7.
    Sass G; Shrestha P; Stevens DA
    Pathogens; 2021 Apr; 10(5):. PubMed ID: 33925818
    [No Abstract]   [Full Text] [Related]  

  • 8. Small Colony Variants of Pseudomonas aeruginosa Display Heterogeneity in Inhibiting Aspergillus fumigatus Biofilm.
    Anand R; Moss RB; Sass G; Banaei N; Clemons KV; Martinez M; Stevens DA
    Mycopathologia; 2018 Feb; 183(1):263-272. PubMed ID: 28785939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergy Between
    Sass G; Marsh JJ; Shrestha P; Sabino R; Stevens DA
    Front Cell Infect Microbiol; 2022; 12():817315. PubMed ID: 35493738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are Cystic Fibrosis Aspergillus fumigatus Isolates Different? Intermicrobial Interactions with Pseudomonas.
    Nazik H; Moss RB; Karna V; Clemons KV; Banaei N; Cohen K; Choudhary V; Stevens DA
    Mycopathologia; 2017 Apr; 182(3-4):315-318. PubMed ID: 27822731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The co-colonization prevalence of Pseudomonas aeruginosa and Aspergillus fumigatus in cystic fibrosis: A systematic review and meta-analysis.
    Zhao J; Cheng W; He X; Liu Y
    Microb Pathog; 2018 Dec; 125():122-128. PubMed ID: 30217514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of acute predation with bacteriophage on intermicrobial aggression by Pseudomonas aeruginosa.
    Secor PR; Sass G; Nazik H; Stevens DA
    PLoS One; 2017; 12(6):e0179659. PubMed ID: 28622385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-colonisation with Aspergillus fumigatus and Pseudomonas aeruginosa is associated with poorer health in cystic fibrosis patients: an Irish registry analysis.
    Reece E; Segurado R; Jackson A; McClean S; Renwick J; Greally P
    BMC Pulm Med; 2017 Apr; 17(1):70. PubMed ID: 28431569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas aeruginosa manipulates redox and iron homeostasis of its microbiota partner Aspergillus fumigatus via phenazines.
    Briard B; Bomme P; Lechner BE; Mislin GL; Lair V; Prévost MC; Latgé JP; Haas H; Beauvais A
    Sci Rep; 2015 Feb; 5():8220. PubMed ID: 25665925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factoring in the Complexity of the Cystic Fibrosis Lung to Understand
    Beswick E; Amich J; Gago S
    Pathogens; 2020 Aug; 9(8):. PubMed ID: 32781694
    [No Abstract]   [Full Text] [Related]  

  • 16. Aspergillus-Pseudomonas interaction, relevant to competition in airways.
    Sass G; Nazik H; Penner J; Shah H; Ansari SR; Clemons KV; Groleau MC; Dietl AM; Visca P; Haas H; Déziel E; Stevens DA
    Med Mycol; 2019 Apr; 57(Supplement_2):S228-S232. PubMed ID: 30816973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of Potential
    Chatterjee P; Sass G; Swietnicki W; Stevens DA
    J Fungi (Basel); 2020 Jun; 6(2):. PubMed ID: 32517271
    [No Abstract]   [Full Text] [Related]  

  • 18.
    Scott J; Sueiro-Olivares M; Ahmed W; Heddergott C; Zhao C; Thomas R; Bromley M; Latgé JP; Krappmann S; Fowler S; Bignell E; Amich J
    Front Microbiol; 2019; 10():2311. PubMed ID: 31649650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exposure to the
    Margalit A; Sheehan D; Carolan JC; Kavanagh K
    Microbiology (Reading); 2022 Mar; 168(3):. PubMed ID: 35333152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune responses to Aspergillus fumigatus and Pseudomonas aeruginosa antigens in cystic fibrosis and allergic bronchopulmonary aspergillosis.
    Murali PS; Pathial K; Saff RH; Splaingard ML; Atluru D; Kurup VP; Fink JN
    Chest; 1994 Aug; 106(2):513-9. PubMed ID: 7774329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.